KWMG
King Wealth Management Group Portfolio holdings
AUM
$737M
1-Year Return
18.5%
This Quarter Return
+22.19%
1 Year Return
+18.5%
3 Year Return
+82.56%
5 Year Return
+128.54%
10 Year Return
+306.49%
AUM
$340M
AUM Growth
+$109M
(+47%)
Cap. Flow
+$61.1M
Cap. Flow
% of AUM
17.93%
Top 10 Holdings %
Top 10 Hldgs %
52.23%
Holding
161
New
25
Increased
64
Reduced
26
Closed
8
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$17.3M |
| 2 |
iShares Biotechnology ETF
IBB
|
$9.26M |
| 3 |
Walmart
WMT
|
$6.63M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$5.31M |
| 5 |
Johnson & Johnson
JNJ
|
$3.61M |
Top Sells
| 1 |
Comcast
CMCSA
|
$1.66M |
| 2 |
Salesforce
CRM
|
$1.17M |
| 3 |
RTN
Raytheon Company
RTN
|
$972K |
| 4 |
Elevance Health
ELV
|
$387K |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$365K |
Sector Composition
| 1 | Technology | 15.72% |
| 2 | Healthcare | 9.27% |
| 3 | Financials | 8.83% |
| 4 | Consumer Discretionary | 7.87% |
| 5 | Consumer Staples | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
AT&T
T
$211B
| $1M | 0.29% |
43,858
+10
| +0% | +$228 |
|
52
Abbott
ABT
$232B
| $986K | 0.29% |
10,788
+201
| +2% | +$18.4K |
|
53
United Therapeutics
UTHR
$17.4B
| $968K | 0.28% |
8,000
+5,000
| +167% | +$605K |
|
54
TG Therapeutics
TGTX
$4.94B
| $951K | 0.28% |
48,800
| – | – |
|
55
Eli Lilly
LLY
$663B
| $936K | 0.27% |
5,702
+3,000
| +111% | +$492K |
|
56
Alphabet (Google) Class A
GOOGL
$2.74T
| $922K | 0.27% |
13,000
| – | – |
|
57
Sanofi
SNY
$112B
| $919K | 0.27% |
18,000
+9,000
| +100% | +$460K |
|
58
Walt Disney
DIS
$213B
| $918K | 0.27% |
8,234
+729
| +10% | +$81.3K |
|
59
iShares Preferred and Income Securities ETF
PFF
$14.4B
| $895K | 0.26% |
25,861
+806
| +3% | +$27.9K |
|
60
Vanguard Total Stock Market ETF
VTI
$525B
| $859K | 0.25% |
5,486
-1,640
| -23% | -$257K |
|
61
Marathon Petroleum
MPC
$54.4B
| $848K | 0.25% |
22,677
| – | – |
|
62
Viatris
VTRS
$12.1B
| $788K | 0.23% |
49,000
+34,000
| +227% | +$547K |
|
63
General Mills
GIS
$26.6B
| $773K | 0.23% |
12,534
| – | – |
|
64
iShares Core S&P Mid-Cap ETF
IJH
$99.7B
| $753K | 0.22% |
21,180
+9,760
| +85% | +$347K |
|
65
AstraZeneca
AZN
$254B
| $748K | 0.22% |
14,150
| – | – |
|
66
Target
TGT
$42.1B
| $725K | 0.21% |
6,047
+1,901
| +46% | +$228K |
|
67
Boston Scientific
BSX
$160B
| $702K | 0.21% |
20,000
+1,000
| +5% | +$35.1K |
|
68
Bristol-Myers Squibb
BMY
$96.1B
| $683K | 0.2% |
11,619
+6,004
| +107% | +$353K |
|
69
iShares TIPS Bond ETF
TIP
$13.6B
| $659K | 0.19% |
5,355
| – | – |
|
70
IBM
IBM
$228B
| $652K | 0.19% |
5,644
+2,174
| +63% | +$251K |
|
71
Amgen
AMGN
$152B
| $641K | 0.19% |
2,717
-999
| -27% | -$236K |
|
72
Meta Platforms (Facebook)
META
$1.88T
| $637K | 0.19% |
+2,807
| New | +$637K |
|
73
Qorvo
QRVO
$8.36B
| $632K | 0.19% |
5,720
+1,720
| +43% | +$190K |
|
74
Broadcom
AVGO
$1.43T
| $628K | 0.18% |
19,910
+150
| +0.8% | +$4.73K |
|
75
Atlassian
TEAM
$43.7B
| $597K | 0.18% |
+3,312
| New | +$597K |
|